These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25213311)

  • 1. Advances in nanomedicine towards clinical application in oncology and immunology.
    Herreros E; Morales S; Cortés C; Cabaña M; Peñaloza JP; Jara L; Geraldo D; Otero C; Fernández-Ramires R
    Curr Pharm Biotechnol; 2014; 15(9):864-79. PubMed ID: 25213311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches.
    Jäger E; Giacomelli FC
    Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.
    Tan A; Yildirimer L; Rajadas J; De La Peña H; Pastorin G; Seifalian A
    Nanomedicine (Lond); 2011 Aug; 6(6):1101-14. PubMed ID: 21955079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.
    Liu Y; Lou C; Yang H; Shi M; Miyoshi H
    Curr Cancer Drug Targets; 2011 Feb; 11(2):156-63. PubMed ID: 21158720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications and strategies in nanodiagnosis and nanotherapy in lung cancer.
    Woodman C; Vundu G; George A; Wilson CM
    Semin Cancer Biol; 2021 Feb; 69():349-364. PubMed ID: 32088362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size matters--nanotechnology and therapeutics in rheumatology and immunology.
    Henderson CS; Madison AC; Shah A
    Curr Rheumatol Rev; 2014; 10(1):11-21. PubMed ID: 25229497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ins and Outs of Nanoparticle Technology in Neurodegenerative Diseases and Cancer.
    Wilson CM; Magnaudeix A; Naves T; Vincent F; Lalloue F; Jauberteau MO
    Curr Drug Metab; 2015; 16(8):609-32. PubMed ID: 26264207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon Nanotube as a Tool for Fighting Cancer.
    Comparetti EJ; Pedrosa VA; Kaneno R
    Bioconjug Chem; 2018 Mar; 29(3):709-718. PubMed ID: 29072905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.